Arena Pharmaceuticals, Inc. Increase (Decrease) in Contract with Customer, Liability
Arena Pharmaceuticals, Inc. reported Increase (Decrease) in Contract with Customer, Liability of -$1.44 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2021-02-23
- Arena Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2018-12-31 was -$1.22M.
- Arena Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2018-09-30 was -$200.00K.
- Arena Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2018-06-30 was -$200.00K.
- Arena Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2018-03-31 was -$446.00K.
- Arena Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for fiscal 2019 was -$1.44M.
- Arena Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for fiscal 2018 was -$2.06M.
- Arena Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for fiscal 2017 was -$4.40M.
- Arena Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for fiscal 2016 was -$69.08M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$1.44M 10-K · filed 2020-02-27 | |||
| 2018-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | -$1.42M derived: sum of 2 quarters · filed 2021-02-23 | -$1.61M derived: sum of 3 quarters · filed 2021-02-23 | -$2.06M 10-K · filed 2021-02-23 |
| 2018-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$400.00K derived: sum of 2 quarters · filed 2019-11-08 | -$846.00K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | -$200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$646.00K 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | -$446.00K 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | -$4.40M 10-K · filed 2020-02-27 | |||
| 2016-12-31 | -$69.08M 10-K · filed 2019-02-28 |